|
|
Patterson Companies Inc (PDCO) |
|
Patterson Companies Inc 's Comment on Competitors and Industry Peers
We operate in the highly fragmented rehabilitation medical supplies and equipment
industry. Patterson Medical’s competition is generally either locally
or regionally focused. Patterson Medical intends to pursue expansion opportunities
when prudent in order to add products, customers and capabilities, which will
further differentiate Patterson Medical from our competition.
We believe Patterson Medical is the only national player to offer “one-stop
shopping” to our customers. Patterson Medical’s national and international
scale and purchasing power provides us with a favorable cost position and strong
pricing trends relative to our competition.
Overall company Market Share Q3 2022 |
*Market share is calculated based on total revenue.
Who are Patterson Companies Inc 's Competitors?
3m Company
Share Performance
+1.58%
Over The Past 5 Days
|
3m Company
Profile
3M is a diversified technology company with a global presence in the following
markets: health care; industrial; display and graphics; consumer and office; safety,
security and protection services; electronics, telecommunications and electrical;
and transportation. 3M is a global enterprise characterized by substantial intercompany
cooperation in research, manufacturing and marketing of products.
More about 3m Company's Market Share
|
Dentsply Sirona Inc
Share Performance
+24.65%
This Quarter
|
Dentsply Sirona Inc
Profile
DENTSPLY believes it is the world's largest designer, developer, manufacturer
and marketer of a broad range of products for the dental market. The Company's
worldwide headquarters and executive offices are located in York, Pennsylvania.
In addition to the United States (“U.S.”), the Company conducts its business
in over 120 foreign countries, principally through its foreign subsidiaries.
DENTSPLY has a long-established presence in Canada and in the European market,
particularly in Germany, Switzerland, France, Italy and the United Kingdom.
The Company also has a significant market presence in Central and South America
including Brazil, Mexico, Argentina, Colombia and Chile; in South Africa; and
in the Pacific Rim including Japan, Australia, New Zealand, China (including
Hong Kong), Thailand, India, Philippines, Taiwan, South Korea, Vietnam and Indonesia.
DENTSPLY has also established marketing activities in Moscow, Russia to serve
the countries of the former Soviet Union.
More about Dentsply Sirona Inc 's Market Share
|
Danaher Corporation
Share Performance
-6.87%
One Year
|
Danaher Corporation
Profile
Danaher conducts its operations through two business segments: Process/Environmental
Controls and Tools & Components.
The Process/Environmental Controls segment encompassed four strategic platforms
(Motion, Environmental, Electronic Test, and Product Identification) and three
focused niche businesses (Power Quality, Aerospace and Defense, and Industrial
Controls).
The Tools & Components segment encompasses one strategic platform, Mechanics’
Hand Tools, and five focused niche businesses. Products are distributed by the
Company’s sales personnel and independent representatives to distributors, end-users,
and original equipment manufacturers.
More about Danaher Corporation's Market Share
|
Kimberly clark Corporation
Share Performance
-0.09%
Today
|
Kimberly clark Corporation
Profile
The Corporation is principally engaged in the manufacturing and marketing of a
wide range of health and hygiene products around the world. Most of these products
are made from natural or synthetic fibers using advanced technologies in fibers,
nonwovens and absorbency.
The Corporation is organized into operating segments based on product groupings.
These operating segments have been aggregated into three reportable global business
segments: Personal Care; Consumer Tissue; and Business-to-Business. Each reportable
segment is headed by an executive officer who reports to the Chief Executive
Officer and is responsible for the development and execution of global strategies
to drive growth and profitability of the Corporation’s worldwide personal care,
consumer tissue and business-to-business operations.
More about Kimberly clark Corporation's Market Share
|
Helen Of Troy Limited
Share Performance
+1.42%
This Year
|
Helen Of Troy Limited
Profile
We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized
as Helen of Troy Limited in Bermuda in 1994. We are a global consumer products
company offering creative solutions for our customers through a strong portfolio
of well-recognized and widely trusted brands. We have built our market positions
through new product innovation, product quality and competitive pricing. People
around the world use our products every day to help meet their household, health
and beauty needs.
More about Helen Of Troy Limited's Market Share
|
Johnson and Johnson
Share Performance
-8.61%
30 Days
|
Johnson and Johnson
Profile
Johnson & Johnson, is engaged in the manufacture and sale of a broad range
of products in the health care field. Through over 200 operating companies, it
conducts business in virtually all countries of the world. Johnson & Johnson's
primary interest, both historically and currently, has been in products related
to human health and well-being. Johnson & Johnson was organized in the State
of New Jersey in 1887.
More about Johnson and Johnson's Market Share
|
Mckesson Corporation
Share Performance
-3.98%
Over The Past 5 Days
|
Mckesson Corporation
Profile
McKesson Corporation, is a Fortune 16 corporation providing supply, information
and care management products and services designed to reduce costs and improve
quality across the healthcare industry.
We conduct our business through three segments. Through our Pharmaceutical
Solutions segment, we are a leading distributor of ethical and proprietary drugs,
and health and beauty care products throughout North America.
More about Mckesson Corporation's Market Share
|
Stryker Corp
Share Performance
+10.74%
This Year
|
Stryker Corp
Profile
Stryker Corporation is a leader in the worldwide orthopaedic market and is one
of the world's largest medical device companies. Stryker delivers results through
a wide range of capabilities including joint replacements, trauma, spine and micro
implant systems, orthobiologics, powered surgical instruments, surgical navigation
systems and endoscopic products as well as patient handling and emergency medical
equipment. Stryker also provides outpatient physical therapy services in the United
States. Stryker was incorporated in Michigan in 1946 as the successor company
to a business founded in 1941 by Dr. Homer H. Stryker, a leading orthopaedic surgeon
and the inventor of several orthopaedic products.
More about Stryker Corp's Market Share
|
Medtronic Plc
Share Performance
+8.18%
30 Days
|
Medtronic Plc
Profile
Medtronic is a world leading medical technology company, providing lifelong solutions
for people with chronic disease. We are committed to offering market-leading therapies
worldwide to restore patients to fuller, healthier lives. With beginnings in the
treatment of heart disease, we have expanded well beyond our historical core business
and today provide a wide range of products and therapies that help solve many
challenging, life-limiting medical conditions. We hold market-leading positions
in almost all of the major markets in which we compete.
More about Medtronic Plc's Market Share
|
Eli Lilly And Company
Share Performance
+41.59%
One Year
|
Eli Lilly And Company
Profile
We discover, develop, manufacture, and sell products in one significant business
segment—pharmaceutical products. Operations of our animal health business segment
are not material to our financial statements. We manufacture and distribute our
products through owned or leased facilities in the United States, Puerto Rico,
and 17 other countries. Our products are sold in approximately 140 countries.
More about Eli Lilly And Company's Market Share
|
Merck and Co Inc
Share Performance
+5.93%
This Quarter
|
Merck and Co Inc
Profile
Merck & Co., Inc., is a global research-driven pharmaceutical products company
that discovers, develops, manufactures and markets a broad range of innovative
products to improve human and animal health, directly and through its joint ventures.
The Company sells its products primarily to drug wholesalers and retailers, hospitals,
clinics, government agencies and managed health care providers such as health
maintenance organizations and other institutions. The Company’s professional representatives
communicate the effectiveness, safety and value of its products to health care
professionals in private practice, group practices and managed care organizations.
More about Merck and Co Inc 's Market Share
|
Pfizer Inc
Share Performance
-12.22%
30 Days
|
Pfizer Inc
Profile
Pfizer Inc., is a research-based, global pharmaceutical company. We discover,
develop, manufacture and market leading prescription medicines for humans and
animals as well as many of the world’s best-known consumer healthcare products.
The Company was incorporated under the laws of the State of Delaware on June
2, 1942.
More about Pfizer Inc's Market Share
|
Petvivo Holdings Inc
Share Performance
+106.30%
One Year
|
Petvivo Holdings Inc
Profile
We are based in suburban Minneapolis, Minnesota. We are a biomedical device
company, which has been primarily engaged in the business of adapting human
biomedical technology for products to be introduced for commercial sale in the
veterinary market to treat pets and other animals suffering from arthritis and
other afflictions. Our initial product, now being commercialized, is a medical
device featuring injections of patented gel-like biomaterials into the afflicted
body parts of pets or other animals suffering from osteoarthritis. The technology
and manufacturing capability of this product was developed by Gel-Del and acquired
by us for use to treat dogs, horses and other animals, but not for treatment
of human afflictions. While working together pursuant to our initial license
agreement, we and Gel-Del determined to combine our two companies through a
stock exchange merger for the purpose of creating one combined entity utilizing
Gel-Del technology to produce, market, and sell medical products based on Gel-Del
technology for both animals and humans. After lengthy negotiations the parties
entered into a definitive agreement for this merger, which resulted in the consummation
of the merger in April, 2017.
More about Petvivo Holdings Inc 's Market Share
|
|
